Article

Migraine Pathophysiology

Although the exact mechanism of migraine is unknown, it is thought to be caused by a genetic abnormality.

This video reviews migraine pathophysiology and although the exact mechanism is not known, it is thought to be caused by a genetic abnormality that make the neurovascular system hyper-excitable.

Related Videos
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Safety Data on Dupilumab, Ensifentrine for COPD, with MeiLan Han, MD
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
Related Content
Ankeet Bhatt, MD, MBA, ScM | Credit: American Heart Association
November 17th 2024

Understanding NUDGLE-FLU Data from AHA 2024, with Ankeet Bhatt, MD, MBA, ScM

Ankeet Bhatt, MD, MBA Patrick Campbell
Kidney Compass: Atacicept for IgAN with Jonathan Barratt, MD, PhD, at Kidney Week 2024
October 27th 2024

Kidney Compass: Atacicept for IgAN with Jonathan Barratt, MD, PhD, at Kidney Week 2024

Brendon Neuen, MBBS, PhD Shikha Wadhwani, MD, MS
Ellen Sher, MD | Credit: Allergy Partners
November 11th 2024

Ellen Sher, MD: Cross-Specialty Collaboration Can Improve Atopic Dermatitis Management

Ellen Sher, MD Patrick Campbell
Default thumbnail for Diabetes Dialogue, featuring podcast logo and headshots of hosts.
April 17th 2024

Diabetes Dialogue: STEP HFpEF DM and Fair Allocation of Incretin-Based Therapies

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
Jonathan Barratt, PhD | Credit: IgA Nephropathy Foundation
October 27th 2024

ORIGIN OLE Data Solidify Atacicept Disease-Modifying Potential for IgA Nephropathy

Patrick Campbell
Finnian McCausland, MBBCh | Credit: Mass General Brigham
October 25th 2024

Finerenone Use Reduces UACR, New-Onset Macroalbuminuria in Heart Failure Patients

Patrick Campbell
© 2024 MJH Life Sciences

All rights reserved.